VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
EuroPCR 2026: DynamX Bioadaptor Shows 66% Lower TLF vs. DES with Full Vessel Function Restoration at 4 Years
EuroPCR 2026: DynamX Bioadaptor Shows 66% Lower TLF vs. DES with Full Vessel Function Restoration at 4 Years
May 31, 2026 08:00 CST Updated 10:11
Share:
Elixir Medical
Medical Device R&D and Manufacturing Company